Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy

BACKGROUND: Hearing loss is common following chemoradiotherapy for children with medulloblastoma. Compared to photons, proton radiotherapy reduces radiation dose to the cochlea for these patients. Here we examine whether this dosimetric advantage leads to a clinical benefit in audiometric outcomes....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Moeller, Benjamin J, Chintagumpala, Murali, Philip, Jimmy J, Grosshans, David R, McAleer, Mary F, Woo, Shiao Y, Gidley, Paul W, Vats, Tribhawan S, Mahajan, Anita
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123575/
https://ncbi.nlm.nih.gov/pubmed/21635776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-6-58
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires